Syngenta, AG

Diversa achieves milestone for delivery of product candidates

Published in Medicine and Law Weekly, March 18th, 2005

Diversa Corp. (DVSA) has achieved an important product development milestone under its research and development agreement with Syngenta, AG, (SYT), corresponding to a milestone payment of $500,000.

Diversa successfully delivered to Syngenta multiple qualified enzyme candidates for use as animal feed additives.

"This milestone is an excellent example of Diversa's ability to rapidly develop novel enzymes directed at improving the utility of animal feed," stated Jay M. Short, PhD, Diversa's president and CEO. "These product candidates are part of our ongoing efforts to build a high-value portfolio of animal nutrition products with our partner...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2005-03-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry